ReShape Lifesciences Inc. 10-K Cybersecurity GRC - 2024-04-01

Page last updated on July 16, 2024

ReShape Lifesciences Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-04-01 17:18:35 EDT.


10-K filed on 2024-04-01

ReShape Lifesciences Inc. filed a 10-K at 2024-04-01 17:18:35 EDT
Accession Number: 0001558370-24-004559

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY Risk Management and Strategy Our Information and Technology service providers manages the Company’s security program, which is focused on assessing, identifying, and managing cyber risk and information security threats. We evaluate cybersecurity on an ongoing basis, and it is a risk monitored through our overall enterprise risk management program, including by the executive leadership and board of directors, described below under “Governance.” To proactively manage cybersecurity risk in our organization, our management team has instituted a security policy that is available to all employees. To proactively identify, mitigate, and prepare for potential cybersecurity incidents, we maintain both a business continuity plan and cyber incident response plan. We recognize that we are exposed to cybersecurity threats associated with our use of third-party service providers. To minimize the risk and vulnerabilities to our own systems stemming from such use, our Information Technology providers identifies and addresses known cybersecurity risks on a continuous basis. In addition, we stive to minimize cybersecurity risks when we first select or renew a vendor by including cybersecurity risk as part of our overall vendor evaluation and due diligence process. Governance Our Board of Directors and our Audit Committee oversee our enterprise-wide risk management, including with respect to cybersecurity. Our Chief Executive Officer or Chief Financial Officer presents information on our enterprise-wide risks to the Board of Directors at each of its regularly scheduled meetings.

Company Information

NameReShape Lifesciences Inc.
SIC DescriptionSurgical & Medical Instruments & Apparatus
TickerRSLS - Nasdaq
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30